Medinez Hospital And Research Institute Private Limited - Due diligence report

A 360° intelligence report on Medinez Hospital And Research Institute Private Limited: trust score, financial health, credit view, complianc…

2020-01-07 Patna, Bihar Active Unlisted
Connect MCP
MH Medinez Hospital And Research Institute Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Medinez Hospital And Research Institute Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Medinez Hospital And Research Institute Private Limited is assessed as Low Risk with a Trust Score of 78/100. Medinez Hospital And Research Institute Private Limited is an active private limited indian non-government company incorporated in 2020, operating in the Healthcare sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 21 Sep 2026 from the latest processed filings. Medinez Hospital And Research Institute Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MOHAMMAD WAJID ALI 01234567 Director 01/04/2018 6 yrs Approved
AFREEN BANO 01234567 Director 01/04/2018 6 yrs Approved
NASIR EQUBAL NIZAMI 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 65
Growth signals & trust indicators
Latest year revenue grew 1.42.
Asset base grew 2.1x - capacity expansion.
Operating for 6 years.
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 24% in a year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view63/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
02 Feb 2023
Director ceased
MOHAMMAD MAJIBUL ARFIN
07 Jan 2020
Incorporated
Registered with Roc Patna
Director appointed
MOHAMMAD WAJID ALI (Director)
Director appointed
AFREEN BANO (Director)
Director appointed
NASIR EQUBAL NIZAMI (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 0.86 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Lamfer Health Care India Private Limited U85300TN2020PTC139295 Chennai, Tamil Nadu, India
Abp Healthcare Private Limited U85100OR2021PTC035987 Bhubaneswar, Orissa, India
Chandan Diagnostic Limited U85195UP1997PLC022929 Lucknow, Uttar Pradesh, India
Legit Medical Diagnostics And Poly Clinic Private Limited U85100TG2020PTC142712 Nizamabad, Telangana, India
Doctori Duniya Dotcom Private Limited U85191UP2016PTC077050 Gorakhpur, Uttar Pradesh, India
Rajebahadur Heart Foundation Private Limited U85110MH1999PTC119375 Nashik-422 001., Maharashtra, India
Ramdulari Healthcare Private Limited U85110UP2021PTC153359 Varanasi, Uttar Pradesh, India
Babu Ji Care Hospital Private Limited U85100CT2021PTC012474 Arang, Chattisgarh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Medinez Hospital And Research Institute Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Medinez Hospital And Research Institute Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Medinez Hospital And Research Institute Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Medinez Hospital And Research Institute Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Medinez Hospital And Research Institute Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Medinez Hospital And Research Institute Private Limited an active company?

Medinez Hospital And Research Institute Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Medinez Hospital And Research Institute Private Limited financially healthy?

Medinez Hospital And Research Institute Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Medinez Hospital And Research Institute Private Limited?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Medinez Hospital And Research Institute Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Medinez Hospital And Research Institute Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Medinez Hospital And Research Institute Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Medinez Hospital And Research Institute Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.